Sign In
Buy DCTH
$10.33
-0.200 (-1.90%)
At Close: Jun 03, 2026
Delcath Systems Elects Seasoned Finance and Capital Markets Executive Elizabeth Czerepak to its Board of Directors
01:30pm, Wednesday, 19'th Feb 2020
Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that Elizabeth Czerepak, a financial executive and board m
Delcath Systems completes enrollment in FOCUS registration trial DCTH
01:52pm, Monday, 13'th Jan 2020
Delcath Systems completes enrollment in FOCUS registration trial DCTH
Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, today announced it has completed patient enrollment in it
Delcath Systems Announces 1-for-700 Reverse Stock Split to be Effective on December 24, 2019
01:30pm, Thursday, 19'th Dec 2019
Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that the Company’s Board of Directors has authorized a 1-
Delcath Systems to Present at the 12th Annual LD Micro Main Event on December 10, 2019
01:30pm, Tuesday, 03'rd Dec 2019
NEW YORK, Dec. 03, 2019 -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today.
Delcath Systems Announces Postponement of Reverse Stock Split
11:27am, Tuesday, 22'nd Oct 2019
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Melphalan/HDS has not been approved by the U.S. Food & Drug Administratio
Delcath Systems Announces Ratio for Reverse Stock Split
12:00pm, Friday, 18'th Oct 2019
Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company’s Board of Directors has authorized a re
MicroCap Rodeo - Investor Conference Lineup for October 15 and 16, 2019
12:00pm, Tuesday, 15'th Oct 2019
AUSTIN, TX / ACCESSWIRE / October 15, 2019 / The MicroCap Rodeo's inaugural event is set for October 15, and 16 th , 2019 in Austin Texas at the Hilton downtown Austin. Focused on the best ideas conce
Delcath Systems to Present at the MicroCap Rodeo Investor Conference
12:00pm, Tuesday, 08'th Oct 2019
Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (DCTH) will present at the MicroCap Rodeo. To schedule a one-on-one meeting, please contact your conference re
Delcath Systems to Participate in Upcoming Investor Conferences
03:30pm, Monday, 23'rd Sep 2019
To schedule a one-on-one meeting, please contact your conference representative or James Carbonara at Hayden IR. Delcath Systems, Inc. is an interventional oncology company focused on the treatment o
MicroCap Rodeo Investor Conference - October 15 and 16, 2019, Austin Texas
02:15pm, Thursday, 19'th Sep 2019
Company lineup is filling up fast with 50 good names in the microcap markets, as well as some great private and Pre-IPO companies AUSTIN, TX / ACCESSWIRE / September 19, 2019 / The MicroCap Rodeo's in
Delcath Systems Announces Presentation at the Rodman & Renshaw 21st Annual Global Investment Conference sponsored by H.C. Wainwright
12:00pm, Wednesday, 28'th Aug 2019
Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (DCTH) will present at the Rodman & Renshaw 21st Annual Global Investment Conference sponsored by H.C. Wainwrig
Delcath Systems Closes $9.5 Million Private Placement
12:00pm, Tuesday, 20'th Aug 2019
NEW YORK, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (DCTH) has closed on its previously announced private placement
Delcath Systems Announces $9.5 Million Private Placement
10:02pm, Thursday, 15'th Aug 2019
Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (DCTH)) today announced that it has entered into a definitive agreement for gross proceeds of approximately $9.
Delcath Enhances Board of Directors With Appointment of Commercial Leader, John R. Sylvester
12:00pm, Monday, 29'th Jul 2019
Seasoned leader with successful track record joins to help Delcath in the next phase of its development. NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTC Pink: DCTH), an inter
